TRIB - Trinity Biotech submits Trinscreen HIV to WHO for approval

Trinity Biotech ([[TRIB]] -1.5%) has submitted its new HIV screening product, TrinScreen HIV, to the World Health Organisation ((WHO)) for approval.It is expected that the WHO will take a number of months to consider the submission, the company said.The company intends to use that time to prepare for automated manufacturing of the test at its facility in Ireland.

For further details see:

Trinity Biotech submits Trinscreen HIV to WHO for approval